Scientists at the Alzheimer’s Center at Temple at the Lewis Katz School of Medicine at Temple University are on the trail of a promising new therapeutic target – ABCA7, a protein known to protect from Alzheimer’s disease. A new study, published online in the journal Cells, uncovers new information about the relationship between ABCA7, cholesterol and inflammation in human brain cells. Joel Wiener, an investigator with the Alzheimer’s Center at Temple, is first author on the report, and Nicholas Lyssenko, PhD, also an investigator with the Alzheimer’s Center at Temple, is corresponding author. Scienmag and ScienceDaily highlighted the news.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH